"BCBP Seminar Series Presents Targeting Stable HIV Reservoirs for HIV Cure Guochun Jiang, Ph.D. Assistant Professor, Department of Biochemistry and Biophysics University of North Carolina-CH Dr. Guochun Jiang received his B.S. in Microbiology from Anhui University in Hefei, China, and his Ph.D. in Radiation Medicine from the Academy of Military Medical Sciences in Beijing, China. He subsequently conducted postdoctoral research at UNC–Chapel Hill and Vanderbilt University. Dr. Jiang’s research focuses on the regulation of HIV transcriptional machinery during both active viral transcription and the establishment of HIV latency. The ultimate goal of his laboratory is to translate insights into HIV transcription and latency into therapeutic interventions."

How close are we to an HIV cure? Join us for a seminar on “Targeting Stable HIV Reservoirs for HIV Cure” with Guochun Jiang, PhD, Assistant Professor, UNC Biochemistry & Biophysics.
1131 Bioinformatics
Tues., April 7 | ⏰ 11:00 AM
#HIVResearch #HIVCure #SeminarSeries #UNC_BCBP

Breakthrough CAR-T Cell Production Method Could Extend Cancer Remission and Advance HIV Cure Research BRONX, — Scientists from Albert Einstein College of Medicine have unveiled a new technique for producing CAR-T immune cells that may dramatically improve how long these engineered cells remain active in the body, potentially strengthening treatments for blood cancers and bringing researchers closer to long-term HIV control. The findings, reported in the journal Science Advances, …

Breakthrough CAR-T Cell Production Method Could Extend Cancer Remission and Advance HIV Cure Research #CancerResearch #CART #HIVCure #Medicine #Immunotherapy

HIV 12: Florida HIV patients get 96 more days. Potential HIV cure research is NOT news for LGBTQXYZ+ media. Followup on HIV cure research mentioned in HIV10 report.

HIV 12: Florida HIV patients get 96 more days. Potential HIV cure research is NOT news for LGBTQXYZ+ media. #gay #HIV #HIVcure
edwardhsebesta.substack.com/p/hiv-12-flo...

From protecting the impact of US-funded #HIV #research to advancing pediatric #HIVcure science and shaping the #STI agenda, this week’s AVAC Roundup tracks what’s next for #HIVprevention.

🔗 avac.org/blog/avac-ro...

🚨 #HIVCure resource alert!

What’s next in the journey toward an #HIV cure?

🎥 Watch key #CROI2026 takeaways with Alison Agwu: www.youtube.com/watch?v=fbTg...

📄 Read the latest from AVAC's Jessica Salzwedel + partners on pediatric HIV cure: academic.oup.com/jpids/articl...

#PAVECollaboratory

HIV 10: Major development HIV cure. But is this new approach going to be pursued URGENTLY. Suppressed HIV may slowly be killing patients. Even when you are undetectable, the HIV infection is likely driving the patient to an early death.

HIV 10: Major development HIV cure. But is this new approach going to be pursued URGENTLY. Suppressed HIV may slowly be killing patients. #gay #HIV #HIVcure
edwardhsebesta.substack.com/p/hiv-10-maj...

New HIV cure approach forces hidden virus into tripping immune sensor Strategy gains momentum after promising results in cell studies and infected people

The Gay Agenda newsletter tracks the scientific press for developments in HIV treatment for the cure. #gay #HIV #HIVcure
www.science.org/content/arti...

Exciting #HIV breakthrough: Scientists "trip" latent virus to trigger immune sensors, offering hope for a functional cure. But: #Innovation needs equitable access & funding! IHPn 869, p32:
www.internationalhealthpolicies.org/wp-content/u...
h/t @ihpnetwork.bsky.social #HIVcure #GlobalHealth

HIV 7: New HIV vaccine technology, DNA scaffolds, is not news for the LGBTQXYZ+ media. Will research move forward? Or not. It has been 45 years and the lack of either a cure or vaccine is unacceptable.

The Gay Agenda newsletter tracks developments in HIV vaccines and cures. We feel that 45+ years has been too long and we plan to do something about it. #HIV #gay #vaccine #cure #HIVvaccine #HIVcure
edwardhsebesta.substack.com/p/hiv-7-new-...

#CROI2026 Community Breakfast Clubs kicked off! We're talking #HIVcure today. There's still time to join.

🔗 Join now: avac-org.zoom.us/meeting/regi...

The Well Project believes #women should be informed and have access to reliable information on what the future of an #HIVcure could look like, where cure research stands right now, and how women can stay meaningfully involved.
We invite you to get connected via our listserv:
➡️ bit.ly/HIVCureTWP

Ending HIV will require sustained investment, transparency, and meaningful community engagement at every stage of research. TAG will continue tracking progress and advocating to ensure cure research moves forward with urgency and equity.

#EndHIV #HIVResearch #HIVCure #ClinicalTrials #PublicHealth

AVAC will be tracking the #HIV and #STI science at #CROI2026: from advances in long-acting #HIV prevention & #HIVcure research to critical discussions on how the global funding crisis is shaping R&D and delivery.

Find ways to follow and join the conversation: avac.org/blog/croi202...

Honored to have delivered a keynote at today’s HIV Cure Symposium in Geneva, organized by Alexandra Calmy (HUG) and Matthieu Perreau (CHUV). Grateful for the inspiring discussions driving progress toward an HIV cure — a commitment we share at @irsicaixa.es. #HIVresearch #HIVcure

The HIV Cure webinar "HIV Cure Research for Children: Where Do PLHIV Fit In?" is now available.

Watch the recording here: youtu.be/s4Xe23S5Sqs

#PLHIVLeadersNow #HIVCure

Are you interested in #HIVcure research and live in the United States? The #Cure Academy offers an opportunity to build knowledge, skills, and a network to advance the #HIV field. Apply before February 13! tinyurl.com/yhrt3fv3

Impact of US Withdrawal from WHO, New Data on PrEP, Cure Academy Applications Open New this week: resources on the impact of harmful US policies on the HIV response; updated infographics on the ups and downs in PrEP; and an opportunity to apply for the US HIV Cure Academy in North…

Today's roundup shows the impact of US policies on the #HIV response, new data on declining #PrEP initiations following #PEPFAR stopwork orders, e a new graphic on how & why delivery of LEN for PrEP is moving faster than any other product + application details US #HIVCure Academy, buff.ly/6Q5Yk37

Momentum continues in the #HIV R&D pipeline— with two early-phase #Vaccine trials, a late-phase monthly #PrEP pill, and advancing #HIVcure research. Stay current on the science shaping prevention and cure in #PxWire:

Are you interested in #HIVcure research and live in the United States? The #Cure Academy offers an opportunity to build knowledge, skills, and a network to advance the #HIV field. Apply before February 13! tinyurl.com/yhrt3fv3

Momentum continues in the #HIV R&D pipeline— with two early-phase #Vaccine trials, a late-phase monthly #PrEP pill, and advancing #HIVcure research. Stay current on the science shaping prevention and cure in #PxWire: buff.ly/tC66sCu

Holo‑RBP4, the #retinol carrier protein, activates #LatentHIV1 #proviruses via pathways independent of #RetinoicAcid, acting in lymphoid tissues and emerging as a natural #latency‑reversing agent to target reservoirs and advance #HIVcure.

#OpenAccess #STTT: doi.org/10.1038/s413...

Directory of HIV subject posts. We need to stop thinking that not having either an HIV vaccine or cure is acceptable. It has been 45 years since the epidemic started.

Directory of HIV subject posts.
We need to stop thinking that not having either an HIV vaccine or cure is acceptable. It has been 45 years since the epidemic started. #gay #HIV #HIVvaccine #HIVcure
edwardhsebesta.substack.com/p/directory-...

3/ in "shock-and-kill" approaches, as we found (link to studies below). Indeed, the authors don't seem to generate evidence for detectable reduction of the reservoir size, and (temporal) virus control seems to be achieved predominantly by T-cell responses. #HIVCure is not around the corner!

1/ I agree that (even functional) #HIVCure will probably need a multi-component and staged strategy, and is not close. This multi-pronged approach shows, 18 months post ATI, a delay of viral rebound in 6/9 participants, and remission in 1/9 participants (though the latter seems to display a

Last month, my team had the great pleasure of hosting a fantastic guest PhD student, Bridget Fisher, from Sharon Lewin's lab at The Peter Doherty Institute for Infection and Immunity, for our collaborative work on #HIVCure. Looking fwd to continuing this exciting joint study. Very well done Bridget!

Natural Human Protein Reactivates Dormant HIV, Bringing Scientists One Step Closer to a Cure A natural vitamin A transporter, RBP4, can awaken latent HIV through NF-κB signalling, offering a new angle for cure strategies. Human immunodeficiency virus (HIV) is a virus that attacks key immune...

Natural Human Protein Reactivates Dormant HIV, Bringing Scientists One Step Closer to a Cure #Science #HealthandMedicine #InfectiousDiseases #HIVCure #HealthResearch

🌍✨ Meet Prof. Sharon Lewin ✨🌍
Join the ISAC–ISID World AIDS Day Webinar
📅 Dec 17 2025
🎤 “Advances in HIV Cure Research”
Global HIV leader, past IAS President, Director Doherty Institute
🔗 Register tinyurl.com/4tmmdrz6
#WorldAIDSDay #HIVCure #GlobalHealth

@isid.org @souhakanj.bsky.social

Welcome! You are invited to join a meeting: The Quest For An HIV Cure - Will It Be Discovered in Africa?. After registering, you will receive a confirmation email about joining the meeting. A definitive cure for HIV remains elusive. So far, only 7 people have been reportedly cured, and all these have been in the global North. Africa remains the continent with the highest burden of HIV,…

Happening in 1 hour! The Quest For An HIV Cure — Will It Be Discovered in Africa?
Join the conversation where leading #HIVcure researchers & @iasociety.bsky.social Vaccine&Cure Fellow explore current research & its potential. Hosted by The Choice Agenda. Register buff.ly/BpZ9Mpg

Absolutely privileged to have met Michel Sidibé, AU Envoy for African Medicines Agency, former @unaids.org Director & Mali Health Minister. Our chat spanned topics ranging from #HIVcure development to implementation. Should a cure be discovered, do we have systems to ensure equitable access?

Long-term HIV control: Could this combination therapy be the key? A study is the first to use a combination of immunotherapies in humans. The results show promise for sustained control of the virus.

Long-Term HIV Control: A Combination Therapy Trial Shows Promise
A new study on a combination of experimental immunotherapies may help people control HIV without long-term antiretroviral treatment — a promising step toward a future cure.
#HIV #HIVtreatment #HIVcure
www.eatg.org/hiv-news/lon...